Life Science Analytics Market Size, Share, Trends and Revenue Forecast [Latest] (2024)

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

1.2.1 INCLUSIONS AND EXCLUSIONS

1.3 MARKET SCOPE

1.3.1 MARKETS COVERED

FIGURE 1 LIFE SCIENCE ANALYTICS: MARKET SEGMENTATION

1.3.2 YEARS CONSIDERED

1.4 CURRENCY CONSIDERED

1.5 STAKEHOLDERS

1.6 SUMMARY OF CHANGES

1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 36)

2.1 RESEARCH DATA

2.2 RESEARCH METHODOLOGY DESIGN

FIGURE 2 LIFE SCIENCE ANALYTICS MARKET SIZE: RESEARCH DESIGN

2.2.1 SECONDARY SOURCES

2.2.1.1 Key data from secondary sources

2.2.2 PRIMARY SOURCES

FIGURE 3 PRIMARY SOURCES

2.2.2.1 Key data from primary sources

2.2.2.2 Key life science industry insights

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS

2.3 MARKET SIZE ESTIMATION

FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS

FIGURE 6 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICSMARKET: REVENUE SHARE ANALYSIS ILLUSTRATION

FIGURE 7 BOTTOM-UP APPROACH

FIGURE 8 GLOBAL MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)

FIGURE 9 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS

FIGURE 10 TOP-DOWN APPROACH

2.4 MARKET BREAKDOWN AND DATA TRIANGULATION

FIGURE 11 DATA TRIANGULATION METHODOLOGY

2.5 MARKET SHARE ESTIMATION

2.6 STUDY ASSUMPTIONS

2.7 LIMITATIONS

2.7.1 METHODOLOGY-RELATED LIMITATIONS

2.7.2 SCOPE-RELATED LIMITATIONS

2.8 RISK ASSESSMENT

TABLE 1 GLOBAL MARKET: RISK ASSESSMENT

2.9 GLOBAL MARKET: RECESSION IMPACT

3 EXECUTIVE SUMMARY (Page No. - 50)

FIGURE 12 LIFE SCIENCE ANALYTICS MARKETSIZE, BY TYPE, 2022 VS. 2027 (USD MILLION)

FIGURE 13 GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)

FIGURE 14 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICSMARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)

FIGURE 15 GLOBAL LIFE SCIENCE INTELLIGENCE MARKET, BY DELIVERY MODEL, 2022 VS. 2027 (USD MILLION)

FIGURE 16 GLOBAL LIFE SCIENCE ANALYTICS MARKETSIZE, BY END USER, 2022 VS. 2027 (USD MILLION)

FIGURE 17 GLOBAL LIFE SCIENCE COMMERCIAL ANALYTICSMARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 54)

4.1 GLOBAL MARKET OVERVIEW

FIGURE 18 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET

4.2 GLOBAL LIFE SCIENCE INTELLIGENCEMARKET, BY TYPE

FIGURE 19 DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE MARKET IN 2021

4.3 GLOBAL LIFE SCIENCE ANALYTICS SOFTWAREMARKET, BY END USER & REGION

FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2021

4.4 GLOBAL MARKET: GEOGRAPHIC SNAPSHOT

FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 58)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 22 LIFE SCIENCE ANALYTICS MARKET SIZE: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

5.2.1 DRIVERS

5.2.1.1 Rising pressure to curb healthcare spending

FIGURE 23 HEALTHCARE SPENDING AS A PERCENTAGE OF GDP, BY COUNTRY (2019)

5.2.1.2 Rising need for improved data standardization

5.2.1.3 Rising technological advancements in analytical solutions

5.2.1.4 Impact of big data on life science

5.2.1.5 Growing adoption of analytical solutions in clinical trials

5.2.1.6 Increasing adoption of analytics for sales & marketing applications

5.2.2 RESTRAINTS

5.2.2.1 High implementation cost of advanced analytical solutions

5.2.2.2 Data privacy concerns

5.2.3 OPPORTUNITIES

5.2.3.1 Growing focus on value-based care

5.2.3.2 Use of analytics in precision & personalized medicine

5.2.3.3 Big data analytics for R&D productivity

5.2.4 CHALLENGES

5.2.4.1 Issues associated with data integration

5.2.4.2 Shortage of skilled personnel

5.3 ECOSYSTEM ANALYSIS

5.4 VALUE CHAIN ANALYSIS

FIGURE 24 GLOBAL LIFE SCIENCE ANALYTICS SOFTWAREMARKET: VALUE CHAIN ANALYSIS

5.5 PORTER’S FIVE FORCES ANALYSIS

5.5.1 THREAT FROM NEW ENTRANTS

5.5.2 THREAT FROM SUBSTITUTES

5.5.3 BARGAINING POWER OF SUPPLIERS

5.5.4 BARGAINING POWER OF BUYERS

5.5.5 INTENSITY OF COMPETITIVE RIVALRY

5.6 TECHNOLOGY ANALYSIS

5.6.1 MACHINE LEARNING

5.6.2 ARTIFICIAL INTELLIGENCE

5.6.3 INTERNET OF THINGS

5.6.4 BIG DATA

5.7 LIFE SCIENCE INDUSTRY TRENDS

5.7.1 INCREASING PARTNERSHIPS & COLLABORATIONS FOR INNOVATION

5.7.2 GROWING DEMAND FOR AI IN PHARMACEUTICAL INDUSTRY

5.8 CASE STUDY ANALYSIS

5.8.1 CASE STUDY 1

5.8.2 CASE STUDY 2

5.8.3 CASE STUDY 3

5.9 REGULATORY ANALYSIS

5.9.1 NORTH AMERICA

5.9.2 EUROPE

5.9.3 ASIA PACIFIC

5.9.4 MIDDLE EAST & AFRICA

5.9.5 LATIN AMERICA

5.10 PRICING ANALYSIS

TABLE 2 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION

5.10.1 AVERAGE SELLING PRICE TREND ANALYSIS

5.11 KEY CONFERENCES AND EVENTS IN 2022–2023

TABLE 3 GLOBAL MARKET: DETAILED LIST OF CONFERENCES AND EVENTS

5.12 KEY STAKEHOLDERS AND BUYING CRITERIA

5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS

FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS

TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)

5.12.2 BUYING CRITERIA

FIGURE 26 KEY BUYING CRITERIA FOR END USERS

TABLE 5 KEY BUYING CRITERIA FOR END USERS